APA (7th ed.) Citation

Ai, X., Mao, F., Shen, S., Shentu, Y., Wang, J., & Lu, S. (2018, April). Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway. BMC Cancer.

Chicago Style (17th ed.) Citation

Ai, Xinghao, Feng Mao, Shengping Shen, Yang Shentu, Jiejun Wang, and Shun Lu. "Bexarotene Inhibits the Viability of Non-small Cell Lung Cancer Cells via Slc10a2/PPARγ/PTEN/mTOR Signaling Pathway." BMC Cancer Apr. 2018.

MLA (9th ed.) Citation

Ai, Xinghao, et al. "Bexarotene Inhibits the Viability of Non-small Cell Lung Cancer Cells via Slc10a2/PPARγ/PTEN/mTOR Signaling Pathway." BMC Cancer, Apr. 2018.